The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Blood Cancer Biological Product Market Research Report 2024

Global Blood Cancer Biological Product Market Research Report 2024

Publishing Date : Jun, 2023

License Type :

Report Code : 1742447

No of Pages : 91

Ask Your Query

Report Description
Table of Content

Synopsis
Global Blood Cancer Biological Product market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Blood Cancer Biological Product market research.

Key manufacturers engaged in the Blood Cancer Biological Product industry include F. Hoffmann-La Roche Ltd., Amgen, Inc., Pfizer, Inc., GSK plc., Bristol-Myers Squibb Company, Abbott, AstraZeneca, Eli Lilly and Company and Gilead Sciences, Inc., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Blood Cancer Biological Product were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Blood Cancer Biological Product market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Blood Cancer Biological Product market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

F. Hoffmann-La Roche Ltd.
Amgen, Inc.
Pfizer, Inc.
GSK plc.
Bristol-Myers Squibb Company
Abbott
AstraZeneca
Eli Lilly and Company
Gilead Sciences, Inc.
Johnson & Johnson Services, Inc.

Segment by Type

Monoclonal Antibody
Recombinant Protein
Growth Inhibitor
Others

Segment by Application

Hospitals
Cancer Centers
Academics & Research Institutes

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Blood Cancer Biological Product report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Blood Cancer Biological Product Market Overview
1.1 Product Overview and Scope of Blood Cancer Biological Product
1.2 Blood Cancer Biological Product Segment by Type
1.2.1 Global Blood Cancer Biological Product Market Value Comparison by Type (2023-2029)
1.2.2 Monoclonal Antibody
1.2.3 Recombinant Protein
1.2.4 Growth Inhibitor
1.2.5 Others
1.3 Blood Cancer Biological Product Segment by Application
1.3.1 Global Blood Cancer Biological Product Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Cancer Centers
1.3.4 Academics & Research Institutes
1.4 Global Blood Cancer Biological Product Market Size Estimates and Forecasts
1.4.1 Global Blood Cancer Biological Product Revenue 2018-2029
1.4.2 Global Blood Cancer Biological Product Sales 2018-2029
1.4.3 Global Blood Cancer Biological Product Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Blood Cancer Biological Product Market Competition by Manufacturers
2.1 Global Blood Cancer Biological Product Sales Market Share by Manufacturers (2018-2023)
2.2 Global Blood Cancer Biological Product Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Blood Cancer Biological Product Average Price by Manufacturers (2018-2023)
2.4 Global Blood Cancer Biological Product Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Blood Cancer Biological Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Cancer Biological Product, Product Type & Application
2.7 Blood Cancer Biological Product Market Competitive Situation and Trends
2.7.1 Blood Cancer Biological Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Blood Cancer Biological Product Players Market Share by Revenue
2.7.3 Global Blood Cancer Biological Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blood Cancer Biological Product Retrospective Market Scenario by Region
3.1 Global Blood Cancer Biological Product Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Blood Cancer Biological Product Global Blood Cancer Biological Product Sales by Region: 2018-2029
3.2.1 Global Blood Cancer Biological Product Sales by Region: 2018-2023
3.2.2 Global Blood Cancer Biological Product Sales by Region: 2024-2029
3.3 Global Blood Cancer Biological Product Global Blood Cancer Biological Product Revenue by Region: 2018-2029
3.3.1 Global Blood Cancer Biological Product Revenue by Region: 2018-2023
3.3.2 Global Blood Cancer Biological Product Revenue by Region: 2024-2029
3.4 North America Blood Cancer Biological Product Market Facts & Figures by Country
3.4.1 North America Blood Cancer Biological Product Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Blood Cancer Biological Product Sales by Country (2018-2029)
3.4.3 North America Blood Cancer Biological Product Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Blood Cancer Biological Product Market Facts & Figures by Country
3.5.1 Europe Blood Cancer Biological Product Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Blood Cancer Biological Product Sales by Country (2018-2029)
3.5.3 Europe Blood Cancer Biological Product Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Cancer Biological Product Market Facts & Figures by Country
3.6.1 Asia Pacific Blood Cancer Biological Product Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Blood Cancer Biological Product Sales by Country (2018-2029)
3.6.3 Asia Pacific Blood Cancer Biological Product Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Blood Cancer Biological Product Market Facts & Figures by Country
3.7.1 Latin America Blood Cancer Biological Product Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Blood Cancer Biological Product Sales by Country (2018-2029)
3.7.3 Latin America Blood Cancer Biological Product Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Blood Cancer Biological Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Cancer Biological Product Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Blood Cancer Biological Product Sales by Country (2018-2029)
3.8.3 Middle East and Africa Blood Cancer Biological Product Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blood Cancer Biological Product Sales by Type (2018-2029)
4.1.1 Global Blood Cancer Biological Product Sales by Type (2018-2023)
4.1.2 Global Blood Cancer Biological Product Sales by Type (2024-2029)
4.1.3 Global Blood Cancer Biological Product Sales Market Share by Type (2018-2029)
4.2 Global Blood Cancer Biological Product Revenue by Type (2018-2029)
4.2.1 Global Blood Cancer Biological Product Revenue by Type (2018-2023)
4.2.2 Global Blood Cancer Biological Product Revenue by Type (2024-2029)
4.2.3 Global Blood Cancer Biological Product Revenue Market Share by Type (2018-2029)
4.3 Global Blood Cancer Biological Product Price by Type (2018-2029)
5 Segment by Application
5.1 Global Blood Cancer Biological Product Sales by Application (2018-2029)
5.1.1 Global Blood Cancer Biological Product Sales by Application (2018-2023)
5.1.2 Global Blood Cancer Biological Product Sales by Application (2024-2029)
5.1.3 Global Blood Cancer Biological Product Sales Market Share by Application (2018-2029)
5.2 Global Blood Cancer Biological Product Revenue by Application (2018-2029)
5.2.1 Global Blood Cancer Biological Product Revenue by Application (2018-2023)
5.2.2 Global Blood Cancer Biological Product Revenue by Application (2024-2029)
5.2.3 Global Blood Cancer Biological Product Revenue Market Share by Application (2018-2029)
5.3 Global Blood Cancer Biological Product Price by Application (2018-2029)
6 Key Companies Profiled
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.1.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.1.3 F. Hoffmann-La Roche Ltd. Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.1.4 F. Hoffmann-La Roche Ltd. Blood Cancer Biological Product Product Portfolio
6.1.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.2 Amgen, Inc.
6.2.1 Amgen, Inc. Corporation Information
6.2.2 Amgen, Inc. Description and Business Overview
6.2.3 Amgen, Inc. Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen, Inc. Blood Cancer Biological Product Product Portfolio
6.2.5 Amgen, Inc. Recent Developments/Updates
6.3 Pfizer, Inc.
6.3.1 Pfizer, Inc. Corporation Information
6.3.2 Pfizer, Inc. Description and Business Overview
6.3.3 Pfizer, Inc. Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer, Inc. Blood Cancer Biological Product Product Portfolio
6.3.5 Pfizer, Inc. Recent Developments/Updates
6.4 GSK plc.
6.4.1 GSK plc. Corporation Information
6.4.2 GSK plc. Description and Business Overview
6.4.3 GSK plc. Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK plc. Blood Cancer Biological Product Product Portfolio
6.4.5 GSK plc. Recent Developments/Updates
6.5 Bristol-Myers Squibb Company
6.5.1 Bristol-Myers Squibb Company Corporation Information
6.5.2 Bristol-Myers Squibb Company Description and Business Overview
6.5.3 Bristol-Myers Squibb Company Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bristol-Myers Squibb Company Blood Cancer Biological Product Product Portfolio
6.5.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Abbott Blood Cancer Biological Product Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Blood Cancer Biological Product Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Corporation Information
6.8.2 Eli Lilly and Company Description and Business Overview
6.8.3 Eli Lilly and Company Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Eli Lilly and Company Blood Cancer Biological Product Product Portfolio
6.8.5 Eli Lilly and Company Recent Developments/Updates
6.9 Gilead Sciences, Inc.
6.9.1 Gilead Sciences, Inc. Corporation Information
6.9.2 Gilead Sciences, Inc. Description and Business Overview
6.9.3 Gilead Sciences, Inc. Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Gilead Sciences, Inc. Blood Cancer Biological Product Product Portfolio
6.9.5 Gilead Sciences, Inc. Recent Developments/Updates
6.10 Johnson & Johnson Services, Inc.
6.10.1 Johnson & Johnson Services, Inc. Corporation Information
6.10.2 Johnson & Johnson Services, Inc. Description and Business Overview
6.10.3 Johnson & Johnson Services, Inc. Blood Cancer Biological Product Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Johnson & Johnson Services, Inc. Blood Cancer Biological Product Product Portfolio
6.10.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Cancer Biological Product Industry Chain Analysis
7.2 Blood Cancer Biological Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Cancer Biological Product Production Mode & Process
7.4 Blood Cancer Biological Product Sales and Marketing
7.4.1 Blood Cancer Biological Product Sales Channels
7.4.2 Blood Cancer Biological Product Distributors
7.5 Blood Cancer Biological Product Customers
8 Blood Cancer Biological Product Market Dynamics
8.1 Blood Cancer Biological Product Industry Trends
8.2 Blood Cancer Biological Product Market Drivers
8.3 Blood Cancer Biological Product Market Challenges
8.4 Blood Cancer Biological Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Medical Coatings Market - Industry Trends and Forecast to 2031

Global Pediatric MRI Systems Market Research Report 2024

Global Oridonin Market Research Report 2024

Global Dual Fetal Monitors Market Research Report 2024

Global Animal Examination Otoscopes Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}